These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 24831280)

  • 1. Implementation of validated pharmacodynamic assays in multiple laboratories: challenges, successes, and limitations.
    Kinders R; Ferry-Galow K; Wang L; Srivastava AK; Ji JJ; Parchment RE
    Clin Cancer Res; 2014 May; 20(10):2578-86. PubMed ID: 24831280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The root causes of pharmacodynamic assay failure.
    Ferry-Galow KV; Makhlouf HR; Wilsker DF; Lawrence SM; Pfister TD; Marrero AM; Bigelow KM; Yutzy WH; Ji JJ; Butcher DO; Gouker BA; Kummar S; Chen AP; Kinders RJ; Parchment RE; Doroshow JH
    Semin Oncol; 2016 Aug; 43(4):484-91. PubMed ID: 27663480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic biomarkers in the development of stratified cancer medicine.
    Figg WD; Newell DR
    Clin Cancer Res; 2014 May; 20(10):2525-9. PubMed ID: 24831275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theory and practice of clinical pharmacodynamics in oncology drug development.
    Parchment RE; Doroshow JH
    Semin Oncol; 2016 Aug; 43(4):427-35. PubMed ID: 27663474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamic analyses in a multi-laboratory network: lessons from the poly(ADP-ribose) assay.
    Ferry-Galow KV; Ji J; Kinders RJ; Zhang Y; Czambel RK; Schmitz JC; Herzog J; Evrard YA; Parchment RE
    Semin Oncol; 2016 Aug; 43(4):492-500. PubMed ID: 27663481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of Good Clinical Laboratory Practice (GCLP) guidelines within the External Quality Assurance Program Oversight Laboratory (EQAPOL).
    Todd CA; Sanchez AM; Garcia A; Denny TN; Sarzotti-Kelsoe M
    J Immunol Methods; 2014 Jul; 409():91-8. PubMed ID: 24120573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards Clinical Application of Methylated DNA Sequences as Cancer Biomarkers: A Joint NCI's EDRN and NIST Workshop on Standards, Methods, Assays, Reagents and Tools.
    Kagan J; Srivastava S; Barker PE; Belinsky SA; Cairns P
    Cancer Res; 2007 May; 67(10):4545-9. PubMed ID: 17510378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [PD-L1 testing in non-small cell lung carcinoma: Guidelines from the PATTERN group of thoracic pathologists].
    Lantuejoul S; Adam J; Girard N; Duruisseaux M; Mansuet-Lupo A; Cazes A; Rouquette I; Gibault L; Garcia S; Antoine M; Vignaud JM; Galateau-Sallé F; Sagan C; Badoual C; Penault-Llorca F; Damotte D;
    Ann Pathol; 2018 Apr; 38(2):110-125. PubMed ID: 29571563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translating pharmacodynamic biomarkers from bench to bedside: analytical validation and fit-for-purpose studies to qualify multiplex immunofluorescent assays for use on clinical core biopsy specimens.
    Marrero A; Lawrence S; Wilsker D; Voth AR; Kinders RJ
    Semin Oncol; 2016 Aug; 43(4):453-63. PubMed ID: 27663477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National survey on the pre-analytical variability in a representative cohort of Italian laboratories.
    Lippi G; Montagnana M; Giavarina D; ; ;
    Clin Chem Lab Med; 2006; 44(12):1491-4. PubMed ID: 17163828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The physician's office laboratory: how does yours measure up?
    Mason CC
    Postgrad Med; 1978 Apr; 63(4):65-7, 70-2. PubMed ID: 345251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of proficiency testing program for laboratories conducting early diagnosis of HIV-1 infection in infants in low- to middle-income countries.
    Garcia A; Subbarao S; Zhang G; Parsons L; Nkengasong J; Ou CY; Ellenberger D
    J Clin Microbiol; 2014 Mar; 52(3):773-80. PubMed ID: 24353004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer biomarker validation: standards and process: roles for the National Institute of Standards and Technology (NIST).
    Barker PE
    Ann N Y Acad Sci; 2003 Mar; 983():142-50. PubMed ID: 12724219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A perspective on challenges and issues in biomarker development and drug and biomarker codevelopment.
    Taube SE; Clark GM; Dancey JE; McShane LM; Sigman CC; Gutman SI
    J Natl Cancer Inst; 2009 Nov; 101(21):1453-63. PubMed ID: 19855077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between performance in three of the Centers for Disease Control microbiology proficiency testing programs and the number of actual patient specimens tested by participating laboratories.
    Griffin CW; Mehaffey MA; Cook EC; Blumer SO; Podeszwik PA
    J Clin Microbiol; 1986 Feb; 23(2):246-50. PubMed ID: 3009532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward implementation of a regional quality assurance program in cytopathology: the Hong Kong experience.
    Ng WK; Chiu CS; Cheng Y; Chan ET; Chiu FL; Collins RJ;
    Acta Cytol; 2006; 50(2):164-77. PubMed ID: 16610684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefits of a comprehensive quality program for cryopreserved PBMC covering 28 clinical trials sites utilizing an integrated, analytical web-based portal.
    Ducar C; Smith D; Pinzon C; Stirewalt M; Cooper C; McElrath MJ; Hural J;
    J Immunol Methods; 2014 Jul; 409():9-20. PubMed ID: 24709391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and implementation of a proficiency testing program for Luminex bead-based cytokine assays.
    Lynch HE; Sanchez AM; D'Souza MP; Rountree W; Denny TN; Kalos M; Sempowski GD
    J Immunol Methods; 2014 Jul; 409():62-71. PubMed ID: 24801479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National Cancer Institute's Precision Medicine Initiatives for the new National Clinical Trials Network.
    Abrams J; Conley B; Mooney M; Zwiebel J; Chen A; Welch JJ; Takebe N; Malik S; McShane L; Korn E; Williams M; Staudt L; Doroshow J
    Am Soc Clin Oncol Educ Book; 2014; ():71-6. PubMed ID: 24857062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of neurokinin a assays in the United States and Europe.
    Mamikunian P; Ardill JE; O'Dorisio TM; Krutzik SR; Vinik AI; Go VL; Armstrong L; Mamikunian G; Woltering EA
    Pancreas; 2011 Oct; 40(7):1000-5. PubMed ID: 21926539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.